Drug name - Rowasa

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7645801 MYLAN SPECIALITY LP Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
Jul, 2027

(4 years from now)

EP2107870A4 MYLAN SPECIALITY LP Improved Reduced Irritant Enema For The Treatment Of Inflammatory Bowel Disease (Ibd)
Jan, 2028

(5 years from now)

EP2107870B1 MYLAN SPECIALITY LP Reduced Irritant Enema For The Treatment Of Inflammatory Bowel Disease (Ibd)
Jan, 2028

(5 years from now)

EP2107870A2 MYLAN SPECIALITY LP Reduced Irritant Enema For The Treatment Of Inflammatory Bowel Disease (Ibd)
Jan, 2028

(5 years from now)

Drugs and Companies using MESALAMINE ingredient

Treatment: NA

Dosage: ENEMA;RECTAL

More Information on Dosage
Strength Dosage Availability
4GM/60ML ENEMA;RECTAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.